Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
Submitted by
admin
on February 26, 2011 - 10:12am
Source:
Yahoo/PR NewsWire
News Tags:
Promacta
chronic immune thrombocytopenic purpura
Headline:
FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
Do Not Allow Advertisers to Use My Personal information
